[1] 彭博,段超超,王春芳.妊娠期高血压疾病视网膜病变的研究现状[J].中西医结合心脑血管病杂志,2021,19(10):1659-1661.
[2] 王妍,王立媛,王静.心痛定联合拉贝洛尔治疗妊娠期高血压疾病效果及患者血清IGF-1、HSP70水平变化[J].山东医药,2021,61(5):72-75.
[3] LEI F,LIU D,SHEN Y,et al.Study on the influence of pregnancy-induced hypertension on neonatal birth weight[J].J Investig Med,2018,66(6):1008-1014.
[4] 曲垟霖,王巍,王强.妊娠期高血压疾病血压控制水平与妊娠结局相关综述分析[J].中国妇幼保健,2018,33(11):2632-2635.
[5] 李明星,谢冰秀,张康婧,等.血清sFRP4和ficolin-3水平与妊娠期糖尿病的相关性研究[J].河北医药,2019,41(19):2951-2954.
[6] MANCUSI C,IZZO R,DI GIOIA G,et al.Insulin resistance the hinge between hypertension and type 2 diabetes[J].High Blood Press Cardiovasc Prev,2020,27(6):515-526.
[7] ALEJANDRO E U,BERNLOHR D A.Window of opportunity:targeting ANGPTL4 improves triglyceride levels in maternal obesity during pregnancy[J].Diabetes,2020,69(6):1087-1089.
[8] 中华医学会妇产科学分会妊娠期高血压疾病学组.妊娠期高血压疾病诊治指南(2020)[J].中华妇产科杂志,2020,55(4):227-238.
[9] YAN Y,LUAN L,XU J.Serum expression of ESM-1,HMWA,and AGEs and its relationship with disease severity in patients with gestational hypertension[J].Comput Math Methods Med,2021,2021(5):9545857-9545862.
[10] 李丽,罗晓梅,张媛媛,等.血清血栓调节蛋白、类血管生成素6和β-痕迹蛋白对妊娠期高血压疾病的诊断价值[J].现代医学,2020,48(10):1276-1279.
[11] JIN Y,XU H,WU M,et al.Correlation of gestational hypertension with abnormal lipid metabolism,insulin resistance and D-dimer and their clinical significance[J].Exp Ther Med,2019,17(2):1346-1350.
[12] YUAN X S,SHI H,WANG H Y,et al.Ficolin-3/adiponectin ratio for the prediction of gestational diabetes mellitus in pregnant women[J].Diabetes Investig,2018,9(2):403-410.
[13] 李桂新,刘士平,徐裕海,等.原发性高血压患者血清ficolin-3、免疫球蛋白、补体及CRP水平研究[J].大连医科大学学报,2016,38(4):367-370.
[14] LORENZO-ALMORÓS A,HANG T,PEIRÓ C,et al.Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases[J].Cardiovasc Diabetol,2019,18(1):140-156.
[15] 林桐梅,高笛.原发性高血压患者血清纤维蛋白胶凝素3水平与颈动脉粥样硬化的相关性研究[J].中华老年心脑血管病杂志,2019,21(6):600-604.
[16] 贾耀辉,陈慧敏,代永庆,等.血清硫氧还蛋白1及纤维胶凝蛋白3水平与老年高血压脑出血患者血肿周围水肿和预后的关系研究[J].中国实用神经疾病杂志,2021,24(21):1889-1899.
[17] 黄志明,王研.血清血管生成素样蛋白水平与冠心病患者Gensini积分的相关性分析[J].心肺血管病杂志,2019,38(8):826-829,847.
[18] 许磊,康亚宁,马静,等.老年2型糖尿病合并高血压患者血管生成素样蛋白4、同型半胱氨酸、血脂水平与颈动脉粥样硬化严重程度的相关性分析[J].中国医学前沿杂志(电子版),2019,11(9):98-102.
[19] 胡丹丹,林霞,曾建.血清脂肪因子血管生成素样蛋白4水平与2型糖尿病下肢血管病变的相关性研究[J].中国糖尿病杂志,2019,27(6):434-437.
[20] 黎鹏飞,刘宗涛,刘涛,等.冠心病患者血清血管生成素样蛋白4水平检测分析[J].微循环学杂志,2020,30(2):49-52.
[21] LIU L,ZHUANG X,JIANG M,et al.ANGPTL4 mediates the protective role of PPARγ activators in the pathogenesis of preeclampsia[J].Cell Death Dis,2017,8(9):e3054-e3066.
[22] LI N,LIU Y,YUN A,et al.Correlation of platelet function with postpartum hemorrhage and venous thromboembolism in patients with gestational hypertension complicated with diabetes[J].Comput Math Methods Med,2022,2022(10):2423333-2423341.
[23] 李姗姗,张琛,颜景玲.妊娠期高血压疾病患者血清LRRFIP1水平与血小板功能的关系[J].中国医药导报,2019,16(33):92-95.
[24] BELMONTE B,MANGOGNA A,GULINO A,et al.Distinct roles of classical and lectin pathways of complement in preeclamptic placentae[J].Front Immunol,2022,13(1):882298-882310. |